Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sulodexide for Chronic Idiopathic Subjective Tinnitus
NCT02737670Phase 2Completed
- Sponsor
- Saint Joseph's University
- Start
- Aug 2014
- Primary completion
- Mar 2017
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in tinnitus comparing Sulodexide with Placebo (2 arms). Primary endpoint: Tinnitus Handicap Inventory at 40 days. Started Aug 2014; status: completed.
02
Drugs
sulodexide
03
Conditions
tinnitus
Beyond the preview
Go deeper on NCT02737670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02737670.